Actively Recruiting

Early Phase 1
Age: 1Month - 18Years
All Genders
NCT04532346

Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes

Led by Children's Hospital of Fudan University · Updated on 2026-03-16

60

Participants Needed

1

Research Sites

134 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The aim of this proposed study is to evaluate the efficacy and safety of hydroxychloroquine (HCQ) in children's interstitial lung diseases(chILD) with genetic causes. This study is a randomized controlled clinical trial.

CONDITIONS

Official Title

Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes

Who Can Participate

Age: 1Month - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • A clinical diagnosis of chILD with age <18 years
  • Genetically diagnosed (e.g. SFTPC, SFTPB, ABCA3, NKX2-1, CSF2RA, CSF2RB, IARS, MARS, COPA, SLC7A7, LRBA)
  • Patients have to be clinically stable with no major changes in their medication in the last 4 weeks
  • No HCQ treatment in the last 12 weeks
  • Signed and dated informed consent of the subject (if subject has the ability) and the representatives (of underaged children) must be available before start of any specific trial procedures
Not Eligible

You will not qualify if you...

  • Acute severe infectious exacerbations
  • Known hypersensitivity to HCQ, or other ingredients of the tablets
  • Proven retinopathy or maculopathy
  • Renal insufficiency at screening, defined as glomerular filtration rate (GFR) < 40 mL/min/1.73 m2 in patients aged 3 to 8 weeks < 60 mL/min/1.73 m2 in patients ≥ 8 weeks of age
  • Participation in other clinical trials during the present clinical trial

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Children's hospital of Fudan University

Shanghai, Shanghai Municipality, China, 201102

Actively Recruiting

Loading map...

Research Team

L

Liling Qian, Doctor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes | DecenTrialz